Fate Therapeutics Inc (FATE) Event June 30, 2022, 20:06 UTC 20 1 comments (10% Negative) FATE THERAPEUTICS, INC. (FATE) Announces Delay in innovation Trials for Solid Tumors San Diego Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment Comment Full text
Curis Inc (CRIS) Event June 30, 2022, 20:05 UTC 20 1 comments (99% Neutral) CURIS INC (CRIS) Announces New Board Appointment Comment Full text
Pacific Biosciences of California Inc (PACB) Event June 30, 2022, 20:05 UTC 20 1 comments (99% Neutral) Pacific Biosciences of California, Inc. (PACB) Announces Business Combination Comment Full text
Blueprint Medicines Corp (BPMC) Event June 30, 2022, 20:05 UTC 20 1 comments (10% Negative) Blueprint Medicines Corporation (BPMC) Announces Business Combination Comment Full text
OncoCyte Corporation (OCX) Event June 30, 2022, 20:05 UTC 20 1 comments (99% Neutral) Oncocyte Corporation (OCX) Announces Executive Changes Comment Full text
Ascendis Pharma (ASND) Event June 30, 2022, 20:01 UTC 19 1 comments (99% Neutral) Ascendis Pharma (ASND) Files Form 6-K Comment Full text
NGM Biopharmaceuticals Inc (was acquired by Atlas Neon Parent, Inc. on 05/04/2024) (NGM) Event June 30, 2022, 20:01 UTC 21 1 comments (99% Neutral) NGM BIOPHARMACEUTICALS INC (NGM) Announces New Board Appointment Comment Full text
Genmab (GMAB) Event June 30, 2022, 18:32 UTC 19 1 comments (70% Positive) Genmab (GMAB) Announces Clinical Development Update (Form 6-K) Comment Full text
Abcellera Biologics Inc (ABCL) Event June 30, 2022, 17:28 UTC 20 1 comments (99% Neutral) ABCELLERA BIOLOGICS INC. (ABCL) Provides Update on authorized for an additional 350 Comment Full text
Sanofi (SNY) Event June 30, 2022, 16:10 UTC 18 1 comments (85% Positive) Sanofi (SNY) Announces Clinical Development Update (Form 6-K) Comment Full text